stoxline Quote Chart Rank Option Currency Glossary
Akerna Corp. (KERN)
0.2873  0.007 (2.61%)    11-29 10:28
Open: 0.284
High: 0.2901
Volume: 40,553
Pre. Close: 0.28
Low: 0.281
Market Cap: 3(M)
Technical analysis
2023-11-29 10:47:58 AM
Short term     
Mid term     
Targets 6-month :  0.37 1-year :  0.44
Resists First :  0.31 Second :  0.37
Pivot price 0.26
Supports First :  0.21 Second :  0.18
MAs MA(5) :  0.28 MA(20) :  0.27
MA(100) :  0.34 MA(250) :  0.65
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  64.9 D(3) :  66.2
RSI RSI(14): 55.6
52-week High :  2.29 Low :  0.17
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ KERN ] has closed below upper band by 28.9%. Bollinger Bands are 38.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.3 - 0.3 0.3 - 0.3
Low: 0.26 - 0.26 0.26 - 0.26
Close: 0.28 - 0.28 0.28 - 0.29
Company Description

Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that offers tracking, reporting, and compliance tools to cannabis cultivators, processors, sellers, and clinics. Further, it provides cannabis cultivation management and compliance software; and cannabis tracking technology that offers seed-to-sale-to-self data. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.

Headline News

Fri, 24 Nov 2023
Will Akerna Corp (KERN) Stay at the Top of the Healthcare Sector? - InvestorsObserver

Mon, 20 Nov 2023
North American Morning Briefing : Stocks Futures Steady on Rates ... -

Thu, 16 Nov 2023
Should You Hold Akerna Corp (KERN) in Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver

Mon, 30 Oct 2023
Where Does Wall Street Think Akerna Corp (KERN) Stock Will Go? - InvestorsObserver

Thu, 19 Oct 2023
Akerna Corp.'s (NASDAQ:KERN) Price Is Right But Growth Is Lacking - Yahoo Finance

Mon, 02 Oct 2023
What is Wall Street's Target Price for Akerna Corp (KERN) Stock Monday? - InvestorsObserver

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Health Information Services
Shares Out 10 (M)
Shares Float 9 (M)
Held by Insiders 19.5 (%)
Held by Institutions 3.4 (%)
Shares Short 86 (K)
Shares Short P.Month 26 (K)
Stock Financials
EPS -2.24
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.12
Profit Margin 0 %
Operating Margin -81 %
Return on Assets (ttm) -20.3 %
Return on Equity (ttm) -363 %
Qtrly Rev. Growth -32 %
Gross Profit (p.s.) 0.8
Sales Per Share 0.95
EBITDA (p.s.) -0.94
Qtrly Earnings Growth 0 %
Operating Cash Flow -6 (M)
Levered Free Cash Flow 2 (M)
Stock Valuations
PE Ratio -0.13
PEG Ratio 0
Price to Book value -0.26
Price to Sales 0.29
Price to Cash Flow -0.53
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android